Skip to main content
Clinical Trials/NCT02040922
NCT02040922
Unknown
Not Applicable

An Observational Study of the Role of Antibiotics, Inflammation and Changes in Microbiota in the Development of Post-infective Bowel Dysfunction Following Infection With Campylobacter Jejuni or Coli

University of Nottingham1 site in 1 country450 target enrollmentJanuary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Campylobacter Infections
Sponsor
University of Nottingham
Enrollment
450
Locations
1
Primary Endpoint
Yes/ no: Post-Infective bowel dysfunction (PI-BD)
Last Updated
9 years ago

Overview

Brief Summary

The principal research objective is to determine the impact of antibiotic use on the risk of developing long term bowel symptoms after infection with the germ Campylobacter.

Detailed Description

The secondary research objectives are: * To investigate how the particular strain of the Campylobacter germ that causes the infection, and the strength of the immune response that it stimulates in the bowel, affect the risk of long term bowel symptoms. * To explore what changes occur after Campylobacter infection in the bacteria that usually live in the large bowel (microbiota) and the chemicals that they produce (short-chain fatty acids) when they digest nutrients. We will look for differences between people who recover fully and people who have long term bowel symptoms.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
June 2017
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical syndrome suggestive of intestinal infection, including symptoms such as new onset of abdominal pain, vomiting, diarrhoea, blood in stools, fever
  • Submission of stool sample to Nottingham University Hospitals Microbiology Laboratory for investigation of these symptoms
  • Campylobacter sp. cultured by selective media (standard clinical practice) from this stool sample

Exclusion Criteria

  • Pregnancy declared by the candidate
  • History declared by the candidate of pre-existing gastrointestinal disorder, including but not limited to:
  • Inflammatory Bowel Disease
  • Coeliac Disease
  • Pancreatitis
  • Gallstone disease (biliary colic, cholecystitis)
  • Diverticulitis
  • Cancer of the gastrointestinal tract
  • Irritable Bowel Syndrome
  • Reported history of previous resection of any part of the gastrointestinal tract other than appendix or gallbladder

Outcomes

Primary Outcomes

Yes/ no: Post-Infective bowel dysfunction (PI-BD)

Time Frame: 12 weeks after microbiological diagnosis of infection

This will be defined by response to the question "have your bowels returned to normal since your Campylobacter infection?"

Secondary Outcomes

  • Yes/ No: Post-Infective irritable bowel syndrome (PI-IBS)(12 weeks after microbiological diagnosis of infection)

Study Sites (1)

Loading locations...

Similar Trials